Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 2230-2232, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sacks, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sacks, D. B.
Related Collections
Right arrow Laboratory Management
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1997;43:2230-2232.)
© 1997 American Association for Clinical Chemistry, Inc.


Editorials

Implications of the Revised Criteria for Diagnosis and Classification of Diabetes Mellitus

David B. Sacks

Department of Pathology, Brigham and Women's Hospital & Harvard Medical School, 75 Francis St., Boston, MA 02115

Diabetes mellitus is a heterogeneous disease. It comprises several distinct pathophysiologic disorders of carbohydrate metabolism, each of which ultimately manifests with hyperglycemia. Although the prevalence of the disease is unknown, >13 million people are estimated to have diabetes in the US (1). The severe complications (renal, retinal, and cardiovascular) associated with the disease contribute to the $92 000 000 000 in annual healthcare costs in the US (1992 estimate) (2). Therefore, the recent Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus that recommends new classification and diagnostic criteria for diabetes (3) merits contemplation.

Since the advent of blood glucose assays, the exclusive criterion for the diagnosis of diabetes has been hyperglycemia, either fasting or postprandial. For many years diabetes was diagnosed by the oral glucose tolerance test (OGTT), the cutoff having been established as 2SD above the mean of the glucose concentrations in healthy volunteers. In 1975 Siperstein estimated that more than half the population older than 60 years was abnormal by these criteria (4). However, those values had more statistical than clinical significance, as follow-up for 10 years revealed that a substantial proportion of these individuals did not develop diabetes and many returned to normal glucose tolerance. Moreover, there was considerable variability among diabetologists in the diagnostic criteria used in practice (5). To resolve these issues, in 1979 the National Diabetes Data Group (6) proposed criteria that were based on the bimodal distribution of blood glucose concentrations in populations with a high prevalence of diabetes, such as Pima Indians and Nauruans. Optimal separation between nondiabetic and diabetic subjects in these groups is at 11.1 mmol/L (200 mg/dL, 2000 mg/L) 2 h after an oral glucose load and at 7.8 mmol/L (140 mg/dL) . . . [Full Text of this Article]


References







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.